August 8, 2000Pannaz Tablets Recalled
CA (SafetyAlerts) - The Food and
Drug Administration (FDA) today reported that Anabolic Laboratories, Inc. is conducting a
recall of Pannaz(tm) Tablets because there was a lack of complete manufacturing process
Pannaz(tm) Tablets, antihistamine-decongestant (Phenylpropanolamine HCl, 75 mg,
Chlorpheniramine Maleate 8 mg, Methscopolamine Nitrate 2.5 mg), in 100-tablet bottles, Rx.
Recall #D-443-0. Class III
Lot #V6337A01 EXP 5/02.
Anabolic Laboratories, Inc., Irvine, California.
Manufacturer, by letter dated June 14, 2000. Firm-initiated recall ongoing. This is
the first public notice issued by the FDA.
9,493 bottles were distributed.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA
Notice of this product warning was sent via email
to SafeMail subscribers August 8,
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.